Bupivacaine Supplementation For Postoperative Pain Control In Surgical Removal Of Mandibular Third Molars
Status:
Unknown status
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
Control of postoperative pain is a foremost goal in achieving a satisfactory postoperative
recovery. Surgical removal of lower third molars is accompanied by postoperative pain that is
at its peak in the first 12 hours. Our study evaluates if the use of 2% lidocaine
hydrochloride for the surgical removal of lower third molars with a postoperative 0.5%
bupivacaine supplementation would result in lesser postoperative pain and a decrease in
ingestion of oral analgesics to control the pain when compared to a placebo.